Increased demand for salbutamol inhalers due to the COVID-19 pandemic has led to reported shortages and limited supply of this product in Canada. Health Canada is taking steps to mitigate the impact of the shortages and is providing advice to Canadians on how to conserve supply. HMC
Stockpiling drugs can lead to local shortages: Canadians urged not to buy more medication than usual during the COVID-19 pandemic
Health Canada understands the stress caused by the COVID-19 pandemic and recognizes that Canadians may be concerned about not being able to get medications they rely on for themselves and their loved ones. While the Government of Canada recommends that Canadians refill their prescriptions now so that they do not have to go to a...
Health Canada updates Canadians on shortage situation involving EpiPen (0.3 mg) auto-injectors
Following Health Canada’s most recent communication regarding a shortage of EpiPen (0.3 mg) and EpiPen Jr (0.15 mg) auto-injectors, Pfizer Canada has advised Health Canada that supply of EpiPen in the 0.3 mg format is expected to be very limited at pharmacies during the month of August. Contact your pharmacies for further updates. HMC
Shortage of EpiPen (0.3 mg) auto-injector in Canada
Pfizer Canada has advised Health Canada that there is currently a shortage of EpiPen auto-injectors in the 0.3 mg format (DIN 00509558). The shortage is reported to be due to a manufacturing disruption and is currently anticipated to be resolved by March 2, 2018. According to Pfizer, the shortage does not impact EpiPen Jr (0.15...